Mavrilimumab to Reduce Progression of Acute Respiratory Failure in COVID-19 Pneumonia and Systemic Hyper-inflammation
Clinical trial NCT04399980 · COMPLETED
Trial details
- NCT number
- NCT04399980
- Sponsor
- The Cleveland Clinic
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2021-04-23
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.